PremiumHealthcare Finance & M&A
The £4.2bn Consolidation: Private Equity's Quiet Reshaping of Specialist Care
Dr. Aris Thorne · 12 min
Venture Capital Retreats from Early-Stage Biotech
Series A funding rounds have plummeted 34%.
By Alastair Thorne•7 min read•
The pipeline problem
The pull-back is already visible in the pre-clinical asset market.
When it turns
Most LPs pointed to Q2 next year.
Share
Related coverage
The Vanadium Brief
Every Monday morning, the definitive analysis of healthcare markets in your inbox.